
Willbe.
Willbe is a UK-based women’s precision health company developing FemGene®, a genomics-driven clinical decision support platform designed to personalise hormone replacement therapy, reduce trial-and-error prescribing and improve treatment outcomes for women in perimenopause and menopause.




